OneSource Specialty Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 326.27 | 481.32 | 342.66 |
| Operating Expense | 241.14 | 241.15 | 337.79 |
| Net Profit | 24.82 | 174.19 | -73.02 |
| Net Profit Margin | 7.61 | 36.19 | -21.31 |
| Earning Per Share | 2.17 | 15.22 | -6.69 |
| EBIDTA | 85.13 | 240.17 | 4.88 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 326.27 |
| Operating Expense | 241.14 |
| Net Profit | 24.82 |
| Net Profit Margin | 7.61 |
| Earning Per Share | 2.17 |
| EBIDTA | 85.13 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 1,299.59 | 171.92 | 38.71 |
| Operating Expenses Annual | 930.31 | 259.44 | 199.33 |
| Operating Profit Annual | 274.02 | -224.69 | -685.89 |
| Interest Annual | 161.65 | 89.42 | 47.55 |
| Depreciation | 100.35 | 81.31 | 109.92 |
| Net Profit Annual | 20 | -364.93 | -429.55 |
| Tax Annual | -41.46 | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 1,299.59 |
| Operating Expenses Annual | 930.31 |
| Operating Profit Annual | 274.02 |
| Interest Annual | 161.65 |
| Depreciation | 100.35 |
| Net Profit Annual | 20 |
| Tax Annual | -41.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 22.19 | 9.41 | 121.47 |
| Cash Flow from Operations | -47.28 | -108.99 | -164.70 |
| Cash Flow from Investing | -300.04 | 505.99 | -65.68 |
| Cash Flow from Financing | 417.22 | -384.22 | 118.32 |
| Cash Flow at the End | 92.09 | 22.19 | 9.41 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 22.19 |
| Cash Flow from Operations | -47.28 |
| Cash Flow from Investing | -300.04 |
| Cash Flow from Financing | 417.22 |
| Cash Flow at the End | 92.09 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 29.71 | -45.51 | -298.97 |
| PBIT Margin (%) | 19.36 | -89.88 | -580.24 |
| PBT Margin (%) | 19.24 | -88.87 | -568.05 |
| Net PROFIT Margin (%) | 1.49 | -227.08 | -2,064.35 |
| Return On Networth / Equity (%) | 3.22 | TBA | TBA |
| Return On Networth /Employed (%) | 5.21 | TBA | TBA |
| Return On Assets (%) | 0.49 | -29.52 | -41.29 |
| Total Debt / Equity (X) | 0.24 | 1.21 | 1.12 |
| Asset Turnover Ratio (%) | 0.33 | 0.13 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 29.71 |
| PBIT Margin (%) | 19.36 |
| PBT Margin (%) | 19.24 |
| Net PROFIT Margin (%) | 1.49 |
| Return On Networth / Equity (%) | 3.22 |
| Return On Networth /Employed (%) | 5.21 |
| Return On Assets (%) | 0.49 |
| Total Debt / Equity (X) | 0.24 |
| Asset Turnover Ratio (%) | 0.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 3,345.81 | 1,007.88 | 1,504.57 |
| Total Current Assets Annual | 1,023.88 | 176.42 | 228.21 |
| Non Current Assets Annual | 6,366.58 | 1,132.16 | 1,780.23 |
| Total Shareholders Funds Annual | 5,920.10 | 397.74 | 786.71 |
| Total Assets Annual | 7,390.46 | 1,308.58 | 2,008.44 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 3,345.81 |
| Total Current Assets Annual | 1,023.88 |
| Non Current Assets Annual | 6,366.58 |
| Total Shareholders Funds Annual | 5,920.10 |
| Total Assets Annual | 7,390.46 |
EPS (INR)
Expected
0.00
Reported
-0.02
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
